Company intelligence / Profile preview

Codman

Plainsboro, New Jersey, United Statesdigilib.unisayogya.ac.id ↗

Ownership: Private
Employees: ~3700
Development stage: Commercial

Overview

Codman's neurosurgery business offers a broad portfolio of commercialized medical devices for hydrocephalus management, neuro intensive care, and cranial surgery. The company was acquired by Integra LifeSciences in 2017 for approximately $1.045 billion and generated net revenues of about $371.5 million in 2016. Its products are widely used globally and include market-leading solutions for intracranial pressure monitoring and cerebrospinal fluid management.

Therapeutic areas: Neurology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Codman.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Codman.

Explore the full profile